Skip to content

These Biotech Stocks Could Get “Let Out Of The Cage” This Year

“Few areas in equities are more volatile than small-cap biotech, biopharma and health care. Combined, these sectors produce more massive winners and horrid losers than any other area of the market,” acknowledges the author of today’s article. With that, he proceeds to highlight a number of biotech stocks that he sees “getting let out of the cage” this year, as well as some holdovers from last year that could prove to be good picks this year. For more, CLICK HERE.